Jeena Sikho Lifecare Ltd

AI
Jeena Sikho Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Jeena Sikho Lifecare Ltd

₹ 508 -0.57%
25 Sep - close price
jeenasikho.com BSE: 544476 NSE: JSLL
About

Jeena Sikho Lifecare is one of the leading ayurvedic healthcare system providers in India. The company is providing healthcare services for the last ten years.

Key Points

Business Segment:[1][2]
a) Hospitals & Clinics Portfolio
Jeena Sikho Lifecare Limited (JSLL) operates a network of 119 active centers (61 hospitals + 58 clinics/day-care centres), across 23 states and 100+ cities/towns. The hospitals have 2300 operational beds, with another 445 beds in the pipeline. 561 beds were added in FY26. ompany has ~592 certified Ayurveda doctors and ~780 supporting healthcare personnel.

Website BSE NSE
  • Market Cap ₹ 6,318 Cr.
  • Current Price ₹ 508
  • High / Low ₹ 840 / 485
  • Stock P/E 26.7
  • Book Value ₹ 37.6
  • Dividend Yield 0.89 %
  • ROCE 64.4 %
  • ROE 61.4 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is expected to give good quarter
  • Company has delivered good profit growth of 84.5% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 49.1%
  • Company has been maintaining a healthy dividend payout of 19.8%
  • Debtor days have improved from 48.1 to 31.8 days.
  • Company's working capital requirements have reduced from 32.2 days to 11.0 days

Cons

  • Stock is trading at 13.5 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Consumer Services Leisure Services Wellness

Part of Nifty Smallcap 500 BSE Consumer Discretionary Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
100 114 116 139 174 190 222 216 224
75 74 86 93 96 98 121 138 132
Operating Profit 25 40 30 46 79 92 101 78 92
OPM % 25% 35% 26% 33% 45% 48% 45% 36% 41%
3 3 0 0 1 1 3 4 14
Interest 1 2 4 3 2 4 3 4 3
Depreciation 5 6 8 9 10 10 11 16 15
Profit before tax 21 35 18 34 69 79 89 62 87
Tax % 23% 25% 26% 25% 25% 25% 25% 26% 25%
16 27 13 25 51 59 67 45 66
EPS in Rs 1.30 2.14 1.06 2.04 4.13 4.73 5.37 3.65 5.28
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
106 94 136 146 204 324 469 801 851
95 84 119 128 158 231 328 450 488
Operating Profit 11 11 17 18 46 93 141 351 363
OPM % 10% 11% 13% 12% 23% 29% 30% 44% 43%
0 1 1 1 2 6 7 8 22
Interest 1 2 1 1 1 0 11 14 15
Depreciation 1 2 2 3 3 5 29 48 53
Profit before tax 8 8 14 15 45 94 108 298 317
Tax % 28% 26% 27% 26% 24% 26% 26% 25%
6 6 10 11 34 69 80 222 237
EPS in Rs 66.67 63.67 93.55 1.24 2.71 5.57 6.43 17.87 19.03
Dividend Payout % 0% 0% 0% 0% 8% 17% 17% 25%
Compounded Sales Growth
10 Years: %
5 Years: 43%
3 Years: 58%
TTM: 57%
Compounded Profit Growth
10 Years: %
5 Years: 85%
3 Years: 88%
TTM: 103%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 67%
1 Year: -37%
Return on Equity
10 Years: %
5 Years: 48%
3 Years: 49%
Last Year: 61%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.10 0.10 0.10 10 14 25 25 25
Reserves 8 14 24 26 112 167 231 443
16 12 12 7 1 1 117 127
12 12 13 18 24 28 46 78
Total Liabilities 36 38 49 62 151 221 419 673
13 17 23 28 60 67 253 292
CWIP 0 0 0 5 1 4 13 3
Investments 0 0 0 0 5 4 4 110
23 21 26 28 86 146 149 269
Total Assets 36 38 49 62 151 221 419 673

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
1 12 18 17 17 37 84 262
-11 -6 -8 -20 -57 -18 -64 -211
7 -5 -2 -5 48 -3 -22 -59
Net Cash Flow -2 1 8 -7 8 15 -2 -8
Free Cash Flow -10 6 9 -1 -13 23 45 231
CFO/OP 35% 130% 125% 118% 55% 66% 84% 96%

Ratios

Standalone / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 15 17 9 22 40 46 66 32
Inventory Days 204 315 208 136 87 121 78 80
Days Payable 125 168 73 109 129 75 106 86
Cash Conversion Cycle 94 163 143 49 -2 92 38 26
Working Capital Days -16 -15 -19 -11 29 58 28 11
ROCE % 38% 50% 39% 53% 58% 41% 64%

Insights

In beta
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Active Operational Centres
centres

Log in to view insights

Please log in to see hidden values.

Login
IPD Patient Volumes
patients
Medicine Order Volumes
lakh orders
OPD Patient Volumes
lakh patients
Operational Beds
beds
Beds Occupied
beds
SKUs in Portfolio
SKUs

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2022Mar 2023Sep 2023Nov 2023Mar 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
65.89% 66.20% 67.91% 67.91% 67.91% 65.84% 63.53% 63.53% 63.61% 63.62% 63.62% 63.62%
0.00% 0.00% 2.00% 1.79% 0.26% 4.05% 5.95% 5.91% 6.59% 6.31% 6.17% 4.78%
0.00% 0.00% 0.04% 0.00% 0.00% 0.07% 0.17% 0.18% 0.15% 0.11% 0.46% 0.36%
34.11% 33.80% 30.05% 30.30% 31.83% 30.04% 30.34% 30.38% 29.65% 29.97% 29.77% 31.24%
No. of Shareholders 8346638151,1072,7213,4235,9676,60316,36222,18125,90543,413

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls